Correction: Promotional mechanism of enhanced denitration activity with Cu modification in a Ce/TiO2-ZrO2 catalyst for a low temperature NH3-SCR system.

[This corrects the article DOI: 10.1039/D1RA06325A.].

Enhancement of catalytic activity in NH3-SCR reaction by promoting dispersibility of CuCe/TiO2-ZrO2 with ultrasonic treatment.

A series of CuCe-modified TiO2-ZrO2 catalysts synthesized by stepwise impregnation method and ultrasonic-assisted impregnation method were investigated to research the removal of NO in the simulated flue gas. Results showed that the CuCe/TiO2-ZrO2 catalyst prepared by ultrasonic-assisted impregnation method exhibited the superior NO conversion, in which higher than 85% NO was degraded at the temperature range of 250-400 °C and the highest NO conversion of 94% at 350 °C. It proves that ultrasonic treatment can markedly improve the performance of catalysts. The effect of ultrasonic enhancement on CuCe/TiO2-ZrO2 was comprehensively studied through being characterized by physicochemical characterization. Results reveal that the ultrasonic cavitation effect improves the distribution of active species and the synergistic interaction between Cu with Ce components (Cu+ + Ce4+ â†” Cu2+ + Ce3+) on the catalysts significantly, thus resulting in better dispersibility as well as a higher ratio of Cu2+ and Ce3+ of the catalysts. Moreover, it was found that the CuCe/TiO2-ZrO2 catalyst prepared by the ultrasonic-assisted impregnation method represented a higher degree of ultrafine metal particles and evenness. The above results were described with the generalized dimension and singularity spectra in multifractal analysis and validated by the comparative test. Therefore, it can be concluded that ultrasonic treatment facilitates the particle size and distribution of active sites on the catalysts.

Promotional mechanism of enhanced denitration activity with Cu modification in a Ce/TiO2-ZrO2 catalyst for a low temperature NH3-SCR system.

This study aims to investigate the enhanced low temperature denitration activity and promotional mechanism of a cerium-based catalyst through copper modification. In this paper, copper and cerium oxides were supported on TiO2-ZrO2 by an impregnation method, their catalytic activity tests of selective catalytic reduction (SCR) of NO with NH3 were carried out and their physicochemical properties were characterized. The CuCe/TiO2-ZrO2 catalyst shows obviously enhanced NH3-SCR activity at low temperature (<300 °C), which is associated with the well dispersed active ingredients and the synergistic effect between copper and cerium species (Cu2+ + Ce3+ ↔ Cu+ + Ce4+), and the increased ratios of surface chemisorbed oxygen and Cu+/Cu2+ lead to the enhanced low-temperature SCR activity. The denitration reaction mechanism over the CuCe/TiO2-ZrO2 catalyst was investigated by in situ DRIFTS and DFT studies. Results illustrate that the NH3 is inclined to adsorb on the Cu acidic sites (Lewis acid sites), and the NH2 and NH2NO species are the key intermediates in the low-temperature NH3-SCR process, which can explain the promotional effect of Cu modification on denitration activity of Ce/TiO2-ZrO2 at the molecular level. Finally, we have reasonably concluded a NH3-SCR catalytic cycle involving the Eley-Rideal mechanism and Langmuir-Hinshelwood mechanism, and the former mechanism dominates in the NH3-SCR reaction.

lncRNA Erbb4-IR is downregulated in prostate carcinoma and predicts prognosis.

Long non-coding (lnc) RNA Erbb4-IR has been associated with diabetic renal injury; however, its roles in other diseases remain unknown. Therefore, the present study investigated the involvement of Erbb4-IR in prostate carcinoma. Reverse transcription-quantitative PCR was used to analyze gene expression in tissue samples collected from patients with prostate carcinoma. Overexpression experiments via cell transfection were performed to determine the association between Erbb4-IR and microRNA (miR)-21. Furthermore, Cell Counting Kit-8 and cell apoptosis assays were performed to assess cell proliferation and apoptotic rate, respectively. The results revealed that Erbb4-IR was downregulated in prostate carcinoma tissues compared with adjacent non-cancerous tissues, and that low expression of Erbb4-IR in tumor tissues was closely associated with poor survival. Furthermore, miR-21 was upregulated in prostate carcinoma tissues compared with adjacent non-cancerous tissues and was inversely associated with Erbb4-IR expression in tumor tissues. In vitro cell experiments revealed that Erbb4-IR overexpression resulted in the downregulation of miR-21, while miR-21 overexpression did not significantly affect the expression of Erbb4-IR. Moreover, Erbb4-IR overexpression increased apoptosis and inhibited the proliferation of prostate carcinoma cells. miR-21 overexpression resulted in the opposite effect and attenuated the effects of Erbb4-IR overexpression. Therefore, the results of the present study suggested that lncRNA Erbb4-IR is downregulated in prostate carcinoma and may inhibit cancer development by downregulating miR-21.